Outcomes of Device-detected Atrial High-rate Episodes in Patients with No Prior History of Atrial Fibrillation: A Systematic Review and Meta-analysis.

IF 2.6 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Arrhythmia & Electrophysiology Review Pub Date : 2024-06-18 eCollection Date: 2024-01-01 DOI:10.15420/aer.2024.11

Hasaan Ahmed, Mahmoud Ismayl, Anirudh Palicherla, Anthony Kashou, Jalal Dufani, Andrew Goldsweig, Nandan Anavekar, Ahmed Aboeata

{"title":"Outcomes of Device-detected Atrial High-rate Episodes in Patients with No Prior History of Atrial Fibrillation: A Systematic Review and Meta-analysis.","authors":"Hasaan Ahmed, Mahmoud Ismayl, Anirudh Palicherla, Anthony Kashou, Jalal Dufani, Andrew Goldsweig, Nandan Anavekar, Ahmed Aboeata","doi":"10.15420/aer.2024.11","DOIUrl":null,"url":null,"abstract":"Background: Outcomes of device-detected AF remain unclear in individuals without a prior history of AF.Methods: A meta-analysis was conducted to evaluate outcomes in individuals with no prior history of AF who experienced device-detected AF. Outcomes assessed were clinical AF, thromboembolism and all-cause mortality. A fixed-effects model was used to calculate RRs with 95% CI.Results: Compared to individuals who did not experience device-detected AF, those who did had increased risks of clinical AF (RR 3.33, 95% CI [1.99.5.57]; p<0.0001) and thromboembolic events (RR 2.21; 95% CI [1.72.2.85]; p<0.0001). The risk of all-cause mortality was similar between both groups (RR 1.19; 95% CI [0.95.1.49]; p=0.13). Subgroup analysis revealed an increased risk of thromboembolic events among device-detected AF .24 hours (RR 12.34; 95% CI [2.70.56.36]).Conclusion: While there is an increased risk of clinical AF and thromboembolism in individuals with device-detected AF, mortality was insignificant.","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":"13 ","pages":"e09"},"PeriodicalIF":2.6000,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11231819/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arrhythmia & Electrophysiology Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/aer.2024.11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Outcomes of device-detected AF remain unclear in individuals without a prior history of AF.

Methods: A meta-analysis was conducted to evaluate outcomes in individuals with no prior history of AF who experienced device-detected AF. Outcomes assessed were clinical AF, thromboembolism and all-cause mortality. A fixed-effects model was used to calculate RRs with 95% CI.

Results: Compared to individuals who did not experience device-detected AF, those who did had increased risks of clinical AF (RR 3.33, 95% CI [1.99.5.57]; p<0.0001) and thromboembolic events (RR 2.21; 95% CI [1.72.2.85]; p<0.0001). The risk of all-cause mortality was similar between both groups (RR 1.19; 95% CI [0.95.1.49]; p=0.13). Subgroup analysis revealed an increased risk of thromboembolic events among device-detected AF .24 hours (RR 12.34; 95% CI [2.70.56.36]).

Conclusion: While there is an increased risk of clinical AF and thromboembolism in individuals with device-detected AF, mortality was insignificant.

查看原文本刊更多论文

既往无心房颤动病史患者的设备检测到的心房高频率发作的结果：系统回顾与元分析》。

背景：对于既往无房颤病史的患者，设备检测出房颤的结果仍不明确：方法：我们进行了一项荟萃分析，以评估既往无房颤病史但经历过设备检测房颤的患者的治疗效果。评估的结果包括临床房颤、血栓栓塞和全因死亡率。采用固定效应模型计算RRs和95% CI：结果：与没有经历过设备检测到房颤的人相比，经历过设备检测到房颤的人发生临床房颤的风险更高（RR 3.33，95% CI [1.99.5.57]；pCI）：虽然装置检测到房颤的患者发生临床房颤和血栓栓塞的风险会增加，但死亡率并不显著。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Arrhythmia & Electrophysiology Review CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

5.10

自引率

6.70%

发文量

审稿时长

7 weeks